Literature DB >> 17450135

Serotonin modulates the response of embryonic thalamocortical axons to netrin-1.

Alexandre Bonnin1, Masaaki Torii, Lilly Wang, Pasko Rakic, Pat Levitt.   

Abstract

Modifying serotonin (5-HT) abundance in the embryonic mouse brain disrupts the precision of sensory maps formed by thalamocortical axons (TCAs), suggesting that 5-HT influences their growth. We investigated the mechanism by which 5-HT influences TCAs during development. 5-HT(1B) and 5-HT(1D) receptor expression in the fetal forebrain overlaps with that of the axon guidance receptors DCC and Unc5c. In coculture assays, axons originating from anterior and posterior halves of the embryonic day 14.5 dorsal thalamus responded differently to netrin-1, reflecting the patterns of DCC and Unc5c expression. 5-HT converts the attraction exerted by netrin-1 on posterior TCAs to repulsion. Pharmacological manipulation of 5-HT(1B/1D) receptors and intracellular cAMP showed the signaling cascade through which this modulation occurs. An in vivo correlate of altered TCA pathfinding was obtained by transient manipulation of 5-HT(1B/1D) receptor expression abundance in the dorsal thalamus by in utero electroporation. These data demonstrate that serotonergic signaling has a previously unrecognized role in the modulation of axonal responsiveness to a classic guidance cue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450135     DOI: 10.1038/nn1896

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  114 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Placental source for 5-HT that tunes fetal brain development.

Authors:  Alexandre Bonnin; Pat Levitt
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

Review 3.  Development and critical period plasticity of the barrel cortex.

Authors:  Reha S Erzurumlu; Patricia Gaspar
Journal:  Eur J Neurosci       Date:  2012-05       Impact factor: 3.386

4.  L1 and CHL1 Cooperate in Thalamocortical Axon Targeting.

Authors:  Galina P Demyanenko; Priscila F Siesser; Amanda G Wright; Leann H Brennaman; Udo Bartsch; Melitta Schachner; Patricia F Maness
Journal:  Cereb Cortex       Date:  2010-06-24       Impact factor: 5.357

5.  Sensorimotor function is modulated by the serotonin receptor 1d, a novel marker for gamma motor neurons.

Authors:  Anders Enjin; Katarina E Leão; Sanja Mikulovic; Pierre Le Merre; Warren G Tourtellotte; Klas Kullander
Journal:  Mol Cell Neurosci       Date:  2012-01-17       Impact factor: 4.314

6.  Maternal Serotonin Levels Are Associated With Cognitive Ability and Core Symptoms in Autism Spectrum Disorder.

Authors:  Alicia K Montgomery; Lauren C Shuffrey; Stephen J Guter; George M Anderson; Suma Jacob; Matthew W Mosconi; John A Sweeney; J Blake Turner; James S Sutcliffe; Edwin H Cook; Jeremy Veenstra-VanderWeele
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-09-24       Impact factor: 8.829

Review 7.  Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain.

Authors:  A Bonnin; P Levitt
Journal:  Neuroscience       Date:  2011-10-08       Impact factor: 3.590

Review 8.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

9.  Expression and function of dopamine receptors in the developing medial frontal cortex and striatum of the rat.

Authors:  S E Sillivan; C Konradi
Journal:  Neuroscience       Date:  2011-10-08       Impact factor: 3.590

Review 10.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.